PERRIGO COMPANY PLC (PRGO) Stock Price

PRGOStock

$14.48−39.06%52W

Market Cap$2.00B

P/E—

PEG Ratio1.14

Div yield3.54%

Beta0.70

PRGO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-12.82%

Price vs S&P 500 (4W)34.04%

PEG Ratio1.14

VGM Score56.84

Indicated Dividend Yield (Annual)3.54%

P/CF (Annual)7.34x

Book Value / Share (Quarterly)$18.14

P/TBV (Annual)3.31x

Indicated Dividend (Annual)$1.16

Revenue Growth (3Y)-1.51%

Cash Flow / Share (Quarterly)$0.86

Payout Ratio (TTM)97.80%

Price vs S&P 500 (YTD)-8.80%

Gross Margin (TTM)33.26%

Net Profit Margin (TTM)-41.85%

EPS (TTM)$-12.59

10-Day Avg Trading Volume2.51M

EPS Excl Extra (TTM)$-12.59

Revenue Growth (5Y)0.79%

EPS (Annual)$-10.29

Dividend / Share (Annual)$1.16

ROI (Annual)-21.68%

Gross Margin (Annual)35.14%

Net Profit Margin (5Y Avg)-8.51%

Cash / Share (Quarterly)$2.88

Revenue Growth QoQ (YoY)-3.17%

ROA (Last FY)-16.70%

Revenue Growth TTM (YoY)-4.19%

EBITD / Share (TTM)$-8.76

ROE (5Y Avg)-11.41%

Operating Margin (TTM)-37.75%

Cash Flow / Share (Annual)$1.05

P/B Ratio0.70x

P/B Ratio (Quarterly)0.55x

Net Income / Employee (Annual)$-176,000

EV / Revenue (TTM)1.12x

Net Interest Coverage (TTM)-6.98x

ROA (TTM)-20.28%

EV / EBITDA (TTM)7.62x

EPS Incl Extra (Annual)$-10.29

Current Ratio (Annual)2.76x

Quick Ratio (Quarterly)1.09x

3-Month Avg Trading Volume3.13M

52-Week Price Return-39.06%

EV / Free Cash Flow (Annual)32.01x

Revenue / Employee (TTM)$511,700

Tangible BV / Share (Quarterly)$1.70

P/S Ratio (Annual)0.41x

Asset Turnover (Annual)0.50x

52-Week High$23.98

Operating Margin (5Y Avg)-1.99%

EPS Excl Extra (Annual)$-10.29

CapEx CAGR (5Y)-14.60%

Tangible BV CAGR (5Y)-26.39%

26-Week Price Return-0.89%

Quick Ratio (Annual)1.44x

13-Week Price Return26.57%

Total Debt / Equity (Annual)1.24x

Current Ratio (Quarterly)2.32x

Enterprise Value$4.64B

Revenue / Share Growth (5Y)0.44%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)-12.88%

Revenue / Employee (Annual)$525,100

Inventory Turnover (Annual)2.47x

Pretax Margin (Annual)-30.52%

Cash / Share (Annual)$3.86

3-Month Return Std Dev67.22%

Gross Margin (5Y Avg)34.68%

Net Income / Employee (TTM)$-214,200

EBITDA CAGR (5Y)-8.13%

EBITDA Interim CAGR (5Y)-3.50%

ROE (Last FY)-48.56%

Net Interest Coverage (Annual)-8.84x

EPS Basic Excl Extra (Annual)$-10.29

P/FCF (TTM)7.09x

Receivables Turnover (TTM)5.69x

EV / Free Cash Flow (TTM)38.94x

Total Debt / Equity (Quarterly)1.31x

EPS Incl Extra (TTM)$-12.59

Receivables Turnover (Annual)6.37x

ROI (TTM)-26.08%

Dividend Growth Rate (5Y)4.76%

P/S Ratio (TTM)0.42x

Pretax Margin (5Y Avg)-5.88%

Revenue / Share (Annual)$30.71

Tangible BV / Share (Annual)$4.21

Forward P/E4.58x

Free OCF CAGR (5Y)-19.55%

Price vs S&P 500 (52W)-57.62%

Year-to-Date Return4.02%

5-Day Price Return1.47%

EPS Normalized (Annual)$-10.29

ROA (5Y Avg)-4.11%

Net Profit Margin (Annual)-33.51%

Month-to-Date Return43.22%

Cash Flow / Share (TTM)$2.81

EBITD / Share (Annual)$-5.91

Operating Margin (Annual)-27.18%

LT Debt / Equity (Annual)1.22x

P/CF (TTM)8.92x

ROI (5Y Avg)-5.27%

LT Debt / Equity (Quarterly)1.30x

EPS Basic Excl Extra (TTM)$-12.59

P/TBV (Quarterly)5.70x

P/B Ratio (Annual)0.65x

Dividend / Share (TTM)$1.16

Inventory Turnover (TTM)2.43x

Pretax Margin (TTM)-38.90%

Book Value / Share (Annual)$21.33

Price vs S&P 500 (13W)24.62%

Dividend Yield (TTM)9.14%

Beta0.70x

P/FCF (Annual)12.06x

Revenue / Share (TTM)$29.69

ROE (TTM)-55.97%

52-Week Low$9.22

vGradeA

gGradeD

mGradeC

vgmGradeC

PRGO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.35	$0.50	+40.85%(+$0.15)
Q1 2026	May 6, 2026	$0.31	$0.43	+40.17%(+$0.12)
Q4 2025	Feb 26, 2026	$0.78	$0.77	-1.28%(-$0.01)
Q3 2025	Nov 5, 2025	$0.77	$0.80	+3.91%(+$0.03)
Q2 2025	Aug 6, 2025	$0.59	$0.57	-4.02%(-$0.02)

PRGO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.80

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
PRGOPERRIGO COMPANY PLC	A	D	C	$14.48
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About PERRIGO COMPANY PLC

Perrigo is a global consumer health company specializing in self-care products. Its North American business, representing approximately two-thirds of sales, operates as a major private-label supplier to retailers including Walmart, Amazon, Costco, and CVS. Internationally, it markets branded products—including Compeed, Solpadeine, Coldrex, and ellaOne—in Europe, Australia, and select Asian markets. The dual strategy balances high-volume private-label revenue with branded product margins.